KANGAROO ISLAND NATURALS Trademark

Trademark Overview


On Monday, May 13, 2013, a trademark application was filed for KANGAROO ISLAND NATURALS with the United States Patent and Trademark Office. The USPTO has given the KANGAROO ISLAND NATURALS trademark a serial number of 79134622. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, March 10, 2022. This trademark is owned by Kangaroo Island Natural Products Pty Ltd. The KANGAROO ISLAND NATURALS trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

[ Pharmaceutical preparations in the nature of acne cleansers for the treatment of acne, anti-bacterials, antifungals, antiviruses and anti-septics for the treatment of skin and soft tissue infections, scalp infections and disorder conditions, oral and dental infections, eye and ear infections, respiratory tract infections, gastro-intestinal tract infections, cardiovascular system infections, systemic infections, urinal tract infections and bacterial vaginosis; Pharmaceutical preparations for the treatment of skin and soft tissue infections, namely, leprosy, carbuncles, staph infections, erysipelas, cellulitis, necrotizing fasciitis, boils, pilonidal cysts and abscesses, impetigo, eczema, psoriasis, seborrheic dermatitis, acne and pimples, wound infections, minor burns, skin ulcers and abrasions, infection of fingernails, toenails and nail beds, ingrown nails, athlete's foot, jock itch, ringworm, yeast infections, cutaneous candidiasis, tinea versicolour, sporotrichosis, molluscum cont...

[ Cosmetics being anti-sun preparations, namely, cosmetic preparations for protecting the skin from the sun's rays, cosmetic sun-protecting preparations and non-medicated sun care preparations; ] Cosmetics, namely, body creams; [ cleaning oils for cosmetic purposes; cosmetic acne cleansers, namely, facial cleaning preparation in the nature of salicylic acne cleanser not for medical purposes and non-medicated acne treatment preparations; cosmetic bath products, namely, bath lotions, bath gels and bubble bath; cosmetic cotton wool; cosmetic preparations for cleansing the mouth, namely, mouth washes and non-medicated mouth rinse; cosmetics; cosmetics for animals; cosmetics for protecting the skin from sunburn; ] cosmetics for the treatment of dry skin; cosmetics for the use on the hair; cosmetics for use on the skin; cosmetics preparations; [ cotton pads for cosmetic use; facial wipes impregnated with cosmetics; hair cosmetics; ] cosmetics, namely, moisturizers; [ cosmetics, namely, nail ...
kangaroo island naturals

General Information


Serial Number79134622
Word MarkKANGAROO ISLAND NATURALS
Filing DateMonday, May 13, 2013
Status706 - SECTION 71 ACCEPTED
Status DateThursday, March 10, 2022
Registration Number4697591
Registration DateTuesday, March 10, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements


Description of MarkThe mark consists of the green stylized wording "KANGAROO ISLAND NATURALS". Below the wording is a circle containing a depiction of a nature scene with a flower and bees in the colors green, gray, black, white, brown, yellow and tan. A tan, white and black kangaroo appears to the left of the circle. A black, gray and white kangaroo appears to the right of the circle. A dark green island shape with a fading green color around the island appears below the circle and kangaroos.
Goods and Services[ Pharmaceutical preparations in the nature of acne cleansers for the treatment of acne, anti-bacterials, antifungals, antiviruses and anti-septics for the treatment of skin and soft tissue infections, scalp infections and disorder conditions, oral and dental infections, eye and ear infections, respiratory tract infections, gastro-intestinal tract infections, cardiovascular system infections, systemic infections, urinal tract infections and bacterial vaginosis; Pharmaceutical preparations for the treatment of skin and soft tissue infections, namely, leprosy, carbuncles, staph infections, erysipelas, cellulitis, necrotizing fasciitis, boils, pilonidal cysts and abscesses, impetigo, eczema, psoriasis, seborrheic dermatitis, acne and pimples, wound infections, minor burns, skin ulcers and abrasions, infection of fingernails, toenails and nail beds, ingrown nails, athlete's foot, jock itch, ringworm, yeast infections, cutaneous candidiasis, tinea versicolour, sporotrichosis, molluscum contagiosum, shingles, chickenpox and herpes stomatitis; Pharmaceutical preparations for the treatment of skin disorders, namely, wrinkles, freckles, melasma, varicose veins, flaking skin, eczema, acne, psoriasis, stretch marks, severe dry skin, cracked skin, itching, scaling and scars, skin aging, burns, wound ulcers, seborrhoeic keratoses, warts, pemphigoid, actinic keratosis, lupus, dermatomyositis, vitiligo, keloid, ichthyosis vulgaris, molluscum contagiosum, shingles, chickenpox, herpes stomatitis and vaginal atrophy; Pharmaceutical preparations for the treatment of scalp infections and disorder conditions, namely, dandruff, inflammatory hair loss and folliculitis; Pharmaceutical preparations for the treatment of oral and dental infections, namely, mouth gum and throat infections, mouth ulcers, mouth deodorant and cold sores; Pharmaceutical preparations for the treatment of allergies, namely, hives, lichen planus, insect bites and stings, skin allergies, skin rashes, nappy rash, heat rash and sweat rash; Pharmaceutical preparations for the treatment of sun damage, namely, sun burn, rosacea, solar keratoses, sun spots, skin lesions and melanoma; Pharmaceutical preparations for the treatment of pain and inflammation, muscle, joint and bone disorders, cardiovascular diseases, hyperlipidemia, peripheral circulatory disorders, diabetic and metabolic disorders; Pharmaceutical preparations for health care, namely, antimicrobials, namely, Amoxicillin, Cephalexin, Mupirocin, and Chloramphenicol; antifungal pharmaceutical products, namely, Clotrimazole, Fluconazole, and Terbinafine; anti-yeast pharmaceutical products, namely, Nystatin, and Clotrimazole; antivirus pharmaceutical products, namely, Aciclovir, Famciclovir, and Oseltamivir; anti-septic pharmaceutical products, namely, Cetrimide, Chlorhexidine, and tea tree oil for medical purposes; anti-aging pharmaceutical products, namely, Vitamin A, Vitamin C, Alpha Hydroxy acids, Retinol, Collagen, Elastin, and Resveratrol; anti-oxidant pharmaceutical products, namely, Vitamin E, Lycopene, Resveratrol, and Coenzyme Q10; analgesic and anti-inflammation pharmaceutical products, namely, Aspirin, Ibuprofen, Paracetamol, Celecoxib, Meloxicam, and Corticosteroid; anti-sun care pharmaceutical products, namely, Tretinoin, Avobenzone, Butyl methoxydibenzoylmethane, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone, Titanium dioxide, and Zinc Oxide; after sun care pharmaceutical products, namely, aloe vera for therapeutic purposes, Vitamin B5, Vitamin C, Vitamin E, and petroleum jelly for medical purposes; skin lesion care pharmaceutical products, namely, Fluorouracil, and Imiquimod; skin and body care pharmaceutical products, namely, Tretinoin, Calcipotriol, Coal tar for medical purposes, Benzoyl peroxide, Resorcinol, Salicylic acid, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone, Cetrimide, Chlorhexidine, Vitamin B5, Vitamin C, Vitamin E, Urea, and petroleum jelly for medical purposes; face care pharmaceutical products, namely, Isotretinoin, Benzoyl peroxide, Resorcinol, and Salicylic acid; nail care pharmaceutical products, namely, Amorolfine, Ciclopirox, Clotrimazole, and Terbinafine; burn and wound care pharmaceutical products, namely, Tea tree oil for medical purposes, Medihoney, and Silver sulfadiazine; peripheral circulatory care pharmaceutical products, namely, Chilblain cream, and Gingko biloba tablets for medical purposes; muscle, joint and bone care pharmaceutical products, namely, fish oil for medical purposes, krill oil for medical purposes, Glucosamine and Chondroitin, and Vitamin D; health tonic pharmaceutical products, namely, panax ginseng tablets for medical purposes and ginger tablets for medical purposes; hair and scalp care pharmaceutical products, namely, coal tar for medical purposes, Pinetar for medical purposes, Ciclopirox, Ketoconazole, Mometasone furoate, Piroctone olamine, Salicylic acid, Selenium, Vitamin E, and Zinc pyrithione; cardiovascular protection pharmaceutical products, namely, Aspirin, Atorvastatin, Simvastatin, Rosuvastatin, Resveratrol, and Coenzyme Q10; anti-lipidemia pharmaceutical products, namely, Atorvastatin, Simvastatin, Rosuvastatin, and Fenofibrate; diabetic type 2 care pharmaceutical products, namely, Metformin, Gliclazide, and Resveratrol; anti-allergy pharmaceutical products, namely, Fexofenadine, Cetirizine, Levocetirizine, Betamethasone, Hydrocortisone, Mometasone furoate, Methylprednisolone, and Triamcinolone; insect bites and sting pharmaceutical products, namely, Aluminium sulfate, Cetrimide, Chlorhexidine, and tea tree oil for medical purposes; modulation of immunity pharmaceutical products, namely, Corticosteroid, Cyclosporine, Azathioprine, and Leflunomide; respiratory care pharmaceutical products, namely, Bromhexine, Ipratropium, Salbutamol, Corticosteroid, Tiotropium, and Montelukast; gastro-intestinal tract care pharmaceutical products, namely, Hyoscine butylbromide, Esomeprazole, Omeprazole, and Pantoprazole; Pharmaceutical preparations in the form of lotions, namely, pharmaceutical skin lotions, pharmaceutical preparations in the form of lozenges, namely, medicated lozenges and throat lozenges, pharmaceutical preparations in the form of tablets, namely, allergy tablets and antibiotic tablets; Pharmaceutical moisturizing preparations, namely, medicated skin moisturizers, for use on the skin for the treatment of wrinkles, freckles, melasma, varicose vein, flaking skin, eczema, acne, psoriasis, stretch marks, severe dry skin, cracked skin, itching, scaling and scars, skin aging, burns, wound ulcers, seborrhoeic keratoses, warts, pemphigoid, actinic keratosis, lupus, dermatomyositis, vitiligo, keloid, ichthyosis vulgaris, molluscum contagiosum, shingles, chickenpox, herpes stomatitis, insect bites and stings, skin allergies, hives, lichen planus, skin rashes, nappy rash, heat rash, sweat rash, vaginal atrophy, rosacea, sun damage, sun burn, solar keratoses, sun spots, skin lesion and melanoma; Pharmaceutical preparations for use in the treatment of skin blemishes, in the nature of acne cleansers, namely, liver spots, purpura, seborrheic keratoses, acne, pimples, skin disclouration, dark spots, red spots, white heads, black heads, papules, pustule, rosacea, cystic acne, nodules, sun damaged skin and aging skin; Pharmaceutical preparations for application to the scalp for the treatment of inflammatory hair loss, Tinea capitis, trichotillomania, alopecia areata, seborrheic eczema, dermatitis, cradle cap, psoriasis, dandruff or pityriasis capitis, pityriasis amiantacea, lichen simplex, folliculitis, scalp infection, hair loss, baldness, hair thinning conditions and hair shaft abnormalities; Pharmaceutical preparations for application to the nails for the treatment of eczema, dermatitis and psoriasis of the nail fold, paronychia, fungal infection, onychomycosis, tinea, and athlete's foot, inflammation of the nail fold, nail discoloration and nail thickening; Pharmaceutical preparations for skin care and topical use, namely, Mupirocin, Polymyxin B, Neomycin, Bacitracin, Terbinafine, Clotrimazole, Nystatin, Aciclovir, Penciclovir, Amorolfine, Ciclopirox, Itraconazole, Fluconazole, Ketoconazole, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone, Mometasone furoate, Isotretinoin, Calcipotriol, Coal tar for medical purposes, Pinetar for medical purposes, Piroctone olamine, Benzoyl peroxide, Resorcinol, Salicylic acid, Selenium, Zinc pyrithione, Silver sulfadiazine, Chilblain cream, Aluminium sulfate, Tea tree oil for medical purposes, Cetrimide, Chlorhexidine, Vitamin B5, Vitamin C, Vitamin E, Urea, Petroleum for medical purposes, Tretinoin, Avobenzone, Butyl methoxydibenzoylmethane, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone, Titanium dioxide, Zinc Oxide, Fluorouracil and Imiquimod; Pharmaceutical preparations for animals for the treatment of skin and soft tissue infections, oral and dental infections, eye and ear infections, respiratory tract infections, gastro-intestinal tract infections, urinary tract infections, cardiovascular system infections, systemic infections, severe sepsis, wound ulcers, burns, skin lesions, melanoma, pain and inflammation, cardiovascular diseases, hyperlipidemia, peripheral circulatory disorders, muscle, joint and bone disorders, and diabetic and metabolic disorders; Pharmaceutical preparations for veterinary use, namely, parasiticides and dermatological preparations, namely, Azoles, Fipronil, Imidacloprid, Ivermectin, and Pyrantel; antibiotics pharmaceutical products, namely, Amoxicillin, and Cephalexin; immunotherapy pharmaceutical products, namely, Cyclosporin, and Corticosteroids; nutrition and metabolism pharmaceutical products, namely, Omega-3, and fish oil for medical purposes; musculosketal system pharmaceutical products, namely, Firocoxib, Meloxicam, and fish oil for medical purposes; pain and inflammation pharmaceutical products, namely, Aspirin, Ibuprofen, Firocoxib, Meloxicam, and Naproxen; allergy pharmaceutical products, namely, Clemastine, Chlorpheniramine, Hydroxyzine, Fexofenadine, Cetirizine, and Prednisone; cardiovascular protection pharmaceutical products, namely, Aspirin, and Moxidectin; respiratory pharmaceutical products, namely, Bromhexine, Albuterol, and Corticosteroids; gastro-intestinal tract pharmaceutical products, namely, Hyoscine butylbromide; ] Propolis for pharmaceutical purposes, namely, propolis for medicinal or therapeutic purposes, namely, propolis cream [, propolis lotion, propolis liquid, propolis lozenges and propolis softgel capsules, to treat skin and soft tissue infections and disorder conditions, nail infections and disorder conditions, scalp infections and disorder conditions, oral and dental infections, eye and ear infections, respiratory tract infections, gastro-intestinal tract infections, cardiovascular system infections, systemic infections, urinal tract infections, bacterial vaginosis, itching, allergies, insect bites and stings, rashes, sun burns, rosacea, solar keratoses, skin lesions, melanoma, pain and inflammation, muscle, joint and bone disorders, cardiovascular diseases, hyperlipidemia, peripheral circulatory disorders and diabetic and metabolic disorders; Plant extracts for pharmaceutical use, namely, plant extracts for pharmaceutical purposes, namely, Gingko biloba for medical purposes, Ginger and Panax ginseng for medical purposes, to treat skin and soft tissue infections and disorder conditions, nail infections and disorder conditions, scalp infection and disorder conditions, oral and dental infections, eye and ear infections, respiratory tract infections, gastro-intestinal tract infections, cardiovascular system infections, systemic infections, urinal tract infections, bacterial vaginosis, itching, allergies, insect bites and stings, rashes, sun burn, rosacea, solar keratoses, skin lesions, melanoma, pain and inflammation, muscle, joint and bone disorders, cardiovascular diseases, hyperlipidemia, peripheral circulatory disorders and diabetic and metabolic disorders; Pharmaceutical products derived from natural sources, namely, Amrubicin, Daptomycin, Galantamine, Mycophenolic acid, Nitisinone, Omegacin, Pitavastatin, Rosuvastatin, Fish oil for medical purposes, Krill oil for medical purposes, Vitamin E, Vitamin D, Vitamin C, Collagen Elastin, Lycopene, Selenium, Glucosamine and Chondroitin, Panax ginseng for medical purposes, Ginger for medical purposes, Gingko biloba for medical purposes and Resveratrol; Pharmaceutical preparations containing royal jelly for the treatment of hypertension, hyperlipidemia, inflammation, asthma, hay fever, sleep disorders, insomnia, premenstrual syndrome, stomach ulcers, menopause symptoms, skin disorders, skin nutrition, health tonic, anti-aging, boosting immune system, and hair nutrition; Oils for pharmaceutical purposes, namely, Tea tree oil, Eucalyptus oil, Clove oil, Cinnamon oil, Benzoin oil and Citronella oil all for medical purposes ]
Goods and Services[ Cosmetics being anti-sun preparations, namely, cosmetic preparations for protecting the skin from the sun's rays, cosmetic sun-protecting preparations and non-medicated sun care preparations; ] Cosmetics, namely, body creams; [ cleaning oils for cosmetic purposes; cosmetic acne cleansers, namely, facial cleaning preparation in the nature of salicylic acne cleanser not for medical purposes and non-medicated acne treatment preparations; cosmetic bath products, namely, bath lotions, bath gels and bubble bath; cosmetic cotton wool; cosmetic preparations for cleansing the mouth, namely, mouth washes and non-medicated mouth rinse; cosmetics; cosmetics for animals; cosmetics for protecting the skin from sunburn; ] cosmetics for the treatment of dry skin; cosmetics for the use on the hair; cosmetics for use on the skin; cosmetics preparations; [ cotton pads for cosmetic use; facial wipes impregnated with cosmetics; hair cosmetics; ] cosmetics, namely, moisturizers; [ cosmetics, namely, nail preparation; ] cosmetic nourishing creams; [ cosmetic oils for the skin; non-medicated cosmetic skin balms; ] cosmetics, namely, non-medicated skin care creams; cosmetics, namely, non-mediates skin care lotions; [ cosmetic skin care oils, namely, body oil and face oil; ] cosmetics, namely, non-medicated skin care preparations; cosmetic skin care products, namely, cosmetic creams for skin care, cosmetic preparations for skin care and non-medicated skin serum; non-medicated cosmetic skin cleansing preparations [ ; cosmetics being sun barriers, namely, sun block; cosmetics, namely, sun blocking preparations; cosmetics being sun protection products, namely, sun screen and sun screen preparations; cosmetic sun skin care products, namely, after sun creams, gels and lotions ]
Indication of Colors claimedThe color(s) green, white, brown, gray, black, yellow and tan is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"NATURALS"

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2013
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKangaroo Island Natural Products Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGUILDFORD NSW 2161
AU

Party NameKangaroo Island Natural Products Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGUILDFORD NSW 2161
AU

Party NameKangaroo Island Natural Products Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGUILDFORD NSW 2161
AU

Trademark Events


Event DateEvent Description
Monday, February 6, 2023PARTIAL INVALIDATION PROCESSED BY THE IB
Wednesday, December 7, 2022GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, December 7, 2022GENERIC MADRID TRANSACTION CREATED
Thursday, November 10, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, March 10, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, March 10, 2022REGISTERED-SEC.71 ACCEPTED
Friday, March 4, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 9, 2021TEAS SECTION 71 RECEIVED
Thursday, September 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 7, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 22, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 22, 2015FINAL DISPOSITION PROCESSED
Wednesday, June 10, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Friday, February 13, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 28, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 28, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 10, 2014EXAMINER'S AMENDMENT ENTERED
Monday, November 10, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 10, 2014EXAMINERS AMENDMENT E-MAILED
Monday, November 10, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, November 7, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, October 2, 2014WITHDRAWN FROM PUB OTQR REQUEST
Monday, September 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 12, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 12, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 28, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 28, 2014FINAL REFUSAL E-MAILED
Thursday, August 28, 2014FINAL REFUSAL WRITTEN
Thursday, August 14, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 14, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 8, 2014ASSIGNED TO LIE
Wednesday, August 6, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2014NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2014NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 18, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2013REFUSAL PROCESSED BY IB
Friday, September 6, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 6, 2013REFUSAL PROCESSED BY MPU
Friday, September 6, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 5, 2013NON-FINAL ACTION WRITTEN
Friday, August 30, 2013ASSIGNED TO EXAMINER
Tuesday, August 27, 2013APPLICATION FILING RECEIPT MAILED
Friday, August 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB